We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

155 hedge funds and large institutions have $1.17B invested in TherapeuticsMD in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 31 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 31

86% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 14

28% more call options, than puts

Call options by funds: $7.42M | Put options by funds: $5.8M

18% more capital invested

Capital invested by funds: $987M → $1.17B (+$182M)

8% more funds holding

Funds holding: 144 → 155 (+11)

0.07% more ownership

Funds ownership: 1.45% → 1.53% (+0.07%)

Holders
155
Holders Change
+11
Holders Change %
+7.64%
% of All Funds
3.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
58
Reduced
31
Closed
14
Calls
$7.42M
Puts
$5.8M
Net Calls
+$1.62M
Net Calls Change
-$1.65M

Top Buyers

Rank Fund Capital Flow
1
DCM
Daruma Capital Management
New York
+$27.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$11.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.45M
4
BlackRock
BlackRock
New York
+$9.42M
5
PA
Perceptive Advisors
New York
+$9.19M

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.63M
2
Morgan Stanley
Morgan Stanley
New York
-$1.51M
3
TCM
Tekla Capital Management
Massachusetts
-$1.46M
4
Franklin Resources
Franklin Resources
California
-$1.43M
5
QIM
Quantitative Investment Management
Virginia
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
Loomis, Sayles & Company
26
Loomis, Sayles & Company
Massachusetts
$4.84M +$4.52M +14,760 New
Norges Bank
27
Norges Bank
Norway
$4.7M +$1.53M +5,000 +54%
Ameriprise
28
Ameriprise
Minnesota
$4.37M +$1.2M +3,901 +41%
Goldman Sachs
29
Goldman Sachs
New York
$3.68M -$641K -2,093 -16%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$3.57M -$3.63M -11,838 -52%
Morgan Stanley
31
Morgan Stanley
New York
$3.51M -$1.51M -4,930 -32%
TD Asset Management
32
TD Asset Management
Ontario, Canada
$3.33M +$494K +1,611 +19%
Deutsche Bank
33
Deutsche Bank
Germany
$3.03M +$348K +1,136 +14%
SMH
34
Sanders Morris Harris
Texas
$2.82M -$42.9K -140 -2%
Millennium Management
35
Millennium Management
New York
$2.71M +$2.53M +8,250 New
1CM
36
1492 Capital Management
Wisconsin
$2.41M -$8.88K -29 -0.4%
TCIM
37
TIAA CREF Investment Management
New York
$2.35M -$66.5K -217 -3%
TA
38
Teachers Advisors
New York
$2.32M +$255K +832 +13%
AC
39
Ascend Capital
California
$2.31M +$2.15M +7,028 New
GC
40
Guggenheim Capital
Illinois
$2.13M +$1.99M +6,486 New
Swiss National Bank
41
Swiss National Bank
Switzerland
$2.1M – – –
AllianceBernstein
42
AllianceBernstein
Tennessee
$1.87M – – –
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.83M +$136K +445 +9%
IG
44
ING Group
Netherlands
$1.67M -$79.7K -260 -5%
CWM
45
Cornerstone Wealth Management
Missouri
$1.65M -$183K -598 -78%
Wells Fargo
46
Wells Fargo
California
$1.6M +$165K +540 +12%
Group One Trading
47
Group One Trading
Illinois
$1.48M +$1.05M +3,433 +318%
RJFSA
48
Raymond James Financial Services Advisors
Florida
$1.48M +$73.5K +240 +6%
Natixis Advisors
49
Natixis Advisors
Massachusetts
$1.44M +$1.34M +4,385 New
First Trust Advisors
50
First Trust Advisors
Illinois
$1.14M +$1.06M +3,472 New
1
2
3 4 5

TXMD Hedge Fund Activity: Q3 2018 in Review

155 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q3 2018, worth a combined $1.17B — up 18% from $987M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new TXMD positions and 14 closed out — a net gain of 12 holders — while 58 added to existing stakes and 31 trimmed.

The largest buyer was Daruma Capital Management, opening a new position worth an estimated $27.8M. The largest seller was D.E. Shaw & Co, cutting an estimated $3.63M.

  • 155 institutional investors held TherapeuticsMD (TXMD) as of Q3 2018, up from 144 in Q2 2018.
  • Funds reported $1.17B of TherapeuticsMD stock for Q3 2018, up 18% quarter-over-quarter.
  • 26 funds opened new TherapeuticsMD positions in Q3 2018 and 14 closed out, a net change of +12 holders.
  • The largest TherapeuticsMD buyer in Q3 2018 was Daruma Capital Management, an estimated $27.8M added.
  • The largest TherapeuticsMD seller in Q3 2018 was D.E. Shaw & Co, an estimated $3.63M sold.

Based on aggregated 13F filings for Q3 2018.